IQ Healthy Hearts ETF
HART
HART was delisted on the 19th of August, 2025.
3 hedge funds and large institutions have $6.03M invested in IQ Healthy Hearts ETF in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
0.22% less ownership
Funds ownership: 66.69% → 66.47% (-0.22%)
4% less capital invested
Capital invested by funds: $6.26M → $6.03M (-$226K)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$20.3K |
| 2 |
Morgan Stanley
New York
|
-$33 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NYLIM
1
New York Life Investment Management
New York
| $6.02M | – | – | – |
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $11K | – | – | – |
|
3
JP Morgan Chase
New York
| $484 | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$20.3K | -648 | Closed |
|
|
5
Morgan Stanley
New York
| – | -$33 | -1 | Closed |
|
HART Hedge Fund Activity: Q2 2025 in Review
3 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in IQ Healthy Hearts ETF (HART) for Q2 2025, worth a combined $6.03M — down 3.6% from $6.26M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of HART and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $20.3K sold.
- 3 institutional investors held IQ Healthy Hearts ETF (HART) as of Q2 2025, down from 5 in Q1 2025.
- Funds reported $6.03M of IQ Healthy Hearts ETF stock for Q2 2025, down 3.6% quarter-over-quarter.
- 0 funds opened new IQ Healthy Hearts ETF positions in Q2 2025 and 2 closed out, a net change of -2 holders.
- The largest IQ Healthy Hearts ETF seller in Q2 2025 was UBS Group, an estimated $20.3K sold.
Based on aggregated 13F filings for Q2 2025.